These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1112 related items for PubMed ID: 12668869
21. Facilitative role of prolactin-releasing peptide neurons in oxytocin cell activation after conditioned-fear stimuli. Zhu LL, Onaka T. Neuroscience; 2003; 118(4):1045-53. PubMed ID: 12732249 [Abstract] [Full Text] [Related]
23. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro. Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LA, Kling MA, Angelucci L, D'Agata R. J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244 [Abstract] [Full Text] [Related]
24. A novel function of prolactin-releasing peptide in the control of growth hormone via secretion of somatostatin from the hypothalamus. Iijima N, Matsumoto Y, Yano T, Tanaka M, Yamamoto T, Kakihara K, Kataoka Y, Tamada Y, Matsumoto H, Suzuki N, Hinuma S, Ibata Y. Endocrinology; 2001 Jul; 142(7):3239-43. PubMed ID: 11416047 [Abstract] [Full Text] [Related]
25. Central administration of prolactin-releasing peptide stimulates oxytocin release in rats. Maruyama M, Matsumoto H, Fujiwara K, Noguchi J, Kitada C, Hinuma S, Onda H, Nishimura O, Fujino M, Higuchi T, Inoue K. Neurosci Lett; 1999 Dec 10; 276(3):193-6. PubMed ID: 10612638 [Abstract] [Full Text] [Related]
26. Interactions of dopaminergic and peptidergic factors in the control of prolactin release. Mogg RJ, Samson WK. Endocrinology; 1990 Feb 10; 126(2):728-35. PubMed ID: 2298169 [Abstract] [Full Text] [Related]
27. Prolactin secretion in response to prolactin-releasing peptide and the expression of the prolactin-releasing peptide gene in the medulla oblongata are estrogen dependent in rats. Tokita R, Nakata T, Katsumata H, Konishi S, Onodera H, Imaki J, Minami S. Neurosci Lett; 1999 Dec 03; 276(2):103-6. PubMed ID: 10624802 [Abstract] [Full Text] [Related]
28. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin. Russell SH, Kim MS, Small CJ, Abbott CR, Morgan DG, Taheri S, Murphy KG, Todd JF, Ghatei MA, Bloom SR. J Neuroendocrinol; 2000 Dec 03; 12(12):1213-8. PubMed ID: 11106980 [Abstract] [Full Text] [Related]
29. Effects of adrenomedullin on adrenocorticotropic hormone (ACTH) release in pituitary cell cultures and on ACTH and oxytocin responses to shaker stress in conscious rat. Mimoto T, Nishioka T, Asaba K, Takao T, Hashimoto K. Brain Res; 2001 Dec 20; 922(2):261-6. PubMed ID: 11743958 [Abstract] [Full Text] [Related]
30. Direct action of serotonin on prolactin, growth hormone, corticotropin and luteinizing hormone release in cocultures of anterior and posterior pituitary lobes: autocrine and/or paracrine action of vasoactive intestinal peptide. Balsa JA, Sánchez-Franco F, Pazos F, Lara JI, Lorenzo MJ, Maldonado G, Cacicedo L. Neuroendocrinology; 1998 Nov 20; 68(5):326-33. PubMed ID: 9822800 [Abstract] [Full Text] [Related]
31. Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates. Samson WK, Taylor MM, Follwell M, Ferguson AV. Regul Pept; 2002 Mar 15; 104(1-3):97-103. PubMed ID: 11830283 [Abstract] [Full Text] [Related]
32. The role of endogenous atrial natriuretic peptide in resting and stress-induced release of corticotropin, prolactin, growth hormone, and thyroid-stimulating hormone. Franci CR, Anselmo-Franci JA, McCann SM. Proc Natl Acad Sci U S A; 1992 Dec 01; 89(23):11391-5. PubMed ID: 1333608 [Abstract] [Full Text] [Related]
33. Immunocytochemical localization of prolactin-releasing peptide in the rat brain. Maruyama M, Matsumoto H, Fujiwara K, Kitada C, Hinuma S, Onda H, Fujino M, Inoue K. Endocrinology; 1999 May 01; 140(5):2326-33. PubMed ID: 10218986 [Abstract] [Full Text] [Related]
34. Evaluation of the role for prolactin-releasing peptide in prolactin secretion induced by ether stress and suckling in the rat: comparison with vasoactive intestinal peptide. Watanobe H, Schiöth HB, Wikberg JE, Suda T. Brain Res; 2000 May 19; 865(1):91-6. PubMed ID: 10814736 [Abstract] [Full Text] [Related]
35. Possible inhibitory role of prolactin-releasing peptide for ACTH release associated with running stress. Ohiwa N, Chang H, Saito T, Onaka T, Fujikawa T, Soya H. Am J Physiol Regul Integr Comp Physiol; 2007 Jan 19; 292(1):R497-504. PubMed ID: 16917019 [Abstract] [Full Text] [Related]
36. Prolactin-releasing peptide regulates the cardiovascular system via corticotrophin-releasing hormone. Yamada T, Mochiduki A, Sugimoto Y, Suzuki Y, Itoi K, Inoue K. J Neuroendocrinol; 2009 Jun 19; 21(6):586-93. PubMed ID: 19500229 [Abstract] [Full Text] [Related]
37. Central bombesin activates the hypothalamic-pituitary-adrenal axis. Effects on regional levels and release of corticotropin-releasing hormone and arginine-vasopressin. Kent P, Anisman H, Merali Z. Neuroendocrinology; 2001 Mar 19; 73(3):203-14. PubMed ID: 11307039 [Abstract] [Full Text] [Related]
38. The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Wren AM, Small CJ, Fribbens CV, Neary NM, Ward HL, Seal LJ, Ghatei MA, Bloom SR. Neuroendocrinology; 2002 Nov 19; 76(5):316-24. PubMed ID: 12457042 [Abstract] [Full Text] [Related]
39. Evidence for the presence of gastrin-releasing peptide immunoreactivity in rat anterior pituitary corticotrophs and lactotrophs, AtT20 cells, and GH3 cells: failure to demonstrate participation in local control of hormone release. Houben H, Denef C. Endocrinology; 1991 Jun 19; 128(6):3208-18. PubMed ID: 1645264 [Abstract] [Full Text] [Related]
40. Vasopressin pressor receptor-mediated activation of HPA axis by acute ethanol stress in rats. László FA, Varga C, Pávó I, Gardi J, Vecsernyés M, Gálfi M, Morschl E, László F, Makara GB. Am J Physiol Regul Integr Comp Physiol; 2001 Feb 19; 280(2):R458-65. PubMed ID: 11208575 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]